FDA issued a Warning Letter to Aurobindo Pharma Limited on 5/20/2011 as a result of this inspection.
483 Aurobindo Pharma Limited, Unit VI Dec 2010

483 Aurobindo Pharma Limited, Unit VI Dec 2010

Paul Bonneau FDA, Mihaly Ligmond FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma Limited, Unit VI - Hyderabad, India facility and issued inspectional observations (via FDA 483) on 22 Dec 2010.

Product details

  • Category: Human Drugs
  • Inspection end: 22 Dec 2010
  • Location: Hyderabad, India
  • FEI: 3004021263
Add To Cart